Amarin Corp Plc (AMRN)

[Whalatane]

Irish From mid 2020 to March of 2022 was probably one of the worst times in recent history to launch a new drug like Vascepa .
In my experience with Kaiser and UCSF ...they always wanted a blood draw / lipid panel run when adding a new CV med .
There was no way I was going into a lab to have a blood draw during this time period . I didn't even go for my annual physical .
So even if your MD recommended a new drug like Vascepa ...many IMHO declined it if it required a blood draw in advance .

On top of that sales reps were prohibited from going to MD offices or holding MD " educational " dinners for a lot of this time .
Then throw onto that Dr Nissen claiming R-IT was a false trial due to the MO .

As KM stated in a CC ..failure to launch .

Kiwi